Home » Business » Wyeth Seeks To Block Generic Drug

Wyeth Seeks To Block Generic Drug

Wyeth markets a newer version of the drug and in 2005 discontinued the older version of Zosyn.

By LIFS October 9, 2009 at 1:40 PM
Font size: Decrease font Enlarge font
Drugmaker Wyeth is suing the Food and Drug Administration to block India’s Orchid Chemicals & Pharmaceuticals from a selling a generic version of Zosyn, a powerful antibiotic used in intensive care medicine.

 
The lawsuit claims the FDA’s approval of Orchid’s generic products is “unlawful” and “arbitrary, capricious, an abuse of discretion,” adding that it “permits the marketing of a generic drug product that cannot be safely used in the same manner as the branded product’’ and “seriously endangers patient health.”

Wyeth markets a newer version of the drug and in 2005 discontinued the older version of Zosyn, known chemically as piperacillin and tazobactam, which Orchid has now secured permission from the FDA to sell.
 

Subscribe to comments feed Comments (0 posted)

total: | displaying:

Post your comment

  • Bold
  • Italic
  • Underline
  • Quote

Please enter the code you see in the image:

Captcha
  • Email Email
  • Print Print

Tagged as:

Business | Magazine | October 2009

Rate this article

0
Submit Link

We are looking for the best Indian stories on the web. If you see something interesting, send us a link to the story.